Keywords: Heptatiti C virus, Targeted therapies, Development, Regulations, Clinical trials, FDA, EMA, Guidance

Experts create roadmap for accelerating the development of targeted therapies for hepatitis C virus

Article | 15 December 2010

At a major scientific meeting in Washington DC, USA - Advancing HCV Drug Development: A Collaborative Approach - convened by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in